NeuroServo

IF WE DETECT NEUROLOGICAL PATHOLOGIES EARLY USING A BRAIN-WAVE CAPTURING DEVICE, CAN WE SAVE PATIENT LIVES AND REDUCE HOSPITAL COSTS?


WHAT CHALLENGE DOES NEUROSERVO ADDRESS ?

Postoperative delirium, is a condition affecting 30% to 70% of hospitalized patients aged 65 and over after a major surgery (source: Ely, ICM 2007), dangerous for the patient (permanent cognitive losses) and very expensive for the health system (\\\$16,000 to \\\$64,000 per patient) when diagnosed late. 

NeuroServo has developed a brain wave capture device (EEG) that combines the characteristics of being miniaturized, non-intrusive, portable, instant-use, and motion-resistant. The brain waves are analyzed in real time by the NeuroServo algorithms, allowing the early diagnosis of postoperative delirium. It is time to prove the fullest extent of its benefits with clinical trials initiated in different prestigious hospitals.


DISCOVER NEUROSERVO’S BREAKTHROUGH INNOVATION

NeuroServo initiated clinical trial withs different hospitals in Europe and North America: Hôpital Bichat in Paris, CHU de Nantes, Hôpital Ste-Justine and CHUM in Montréal. Data captured during those trials will help improving our algorithms and will improve science in general.

NeuroServo offers an objective solution that detect delirium after capturing and analyzing the patient’s cerebral wavelengths (E.E.G.). This early detection device of delirium has attracted the attention of internationally recognized neurologists who lead clinical trials just starting in different prestigious hospitals in France.

NeuroServo’s technology is also deployed in a different medical application, in the form of an EEG integrated in a cap, allowing a quick and non-traumatic capture with children in consultation for autistic disorders or AD/HD. The device analyzes the brain waves and determines in real time the patient’s level of attention.



Nicolas Tremblay - Founder and President 
Jérôme Arnaud - Co-founder and COO



HOW DOES THE 3DEXPERIENCE LAB HELP NEUROSERVO ?

NeuroServo joined the 3DEXPERIENCE Lab in 2020


With a comprehensive product-development-software portfolio the 3DEXPERIENCE platform is helping NeuroServo to conceive a better product usable from pediatric to geriatric patients.

The 3DEXPERIENCE platform is also a unique opportunity to prepare a collaborative ecosystem for the external teams or future internal resources to join NeuroServo.


NEUROSERVO’S SUSTAINABLE DEVELOPMENT GOALS 🌍



KEY FACTS

Headquarters :

Montréal, Canada
Founded :03/12/2019
Number of employees :1-10 employees 
Social media:

Linkedin

Twitter: Nicolas Tremblay

Twitter: Jérôme Arnaud

Company website and 3DEXPERIENCE Lab Page

NeuroServo

3DEXPERIENCE Lab​​​​​​​